We would like to thank Huang et al. [1] for their interest and valid comments regarding our recent study published in the March issue of the journal on the potential use of serum cartilage oligomeric matrix protein (COMP) levels as a new non-invasive marker of fibrosis in patients with chronic viral hepatitis (CVH) [2].
